Jane Street’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-1,383
Closed -$16.4K – 10253
2022
Q4
$16.4K Buy
+1,383
New +$15.8K ﹤0.01% 8652
2022
Q3
– Sell
-249
Closed -$9K – 10719
2022
Q2
$9K Buy
+249
New +$7.77K ﹤0.01% 9339
2022
Q1
– Sell
-596
Closed -$25K – 11252
2021
Q4
$25K Buy
596
+437
+275% +$27.3K ﹤0.01% 9746
2021
Q3
$11K Buy
+159
New +$11.6K ﹤0.01% 9805
2021
Q2
– Sell
-218
Closed -$13.3K – 10611
2021
Q1
$15K Buy
+218
New +$17K ﹤0.01% 9001
2020
Q4
– Sell
-290
Closed -$16K – 8285
2020
Q3
$16K Sell
290
-240
-45% -$14.2K ﹤0.01% 7044
2020
Q2
$20K Buy
+530
New +$18.1K ﹤0.01% 6968
2020
Q1
– Sell
-243
Closed -$12K – 6162
2019
Q4
$12K Buy
+243
New +$11.8K ﹤0.01% 4963
2019
Q1
– Sell
-196
Closed -$31K – 5804
2018
Q4
$31K Buy
+196
New +$37.6K ﹤0.01% 4757
2014
Q4
– Sell
-153
Closed -$50K – 3152
2014
Q3
$50K Sell
153
-85
-36% -$24.9K ﹤0.01% 2421
2014
Q2
$80K Buy
238
+7
+3% +$2.75K ﹤0.01% 2388
2014
Q1
$103K Buy
+231
New +$105K ﹤0.01% 2513

Other funds holding DMK

Jane Street's DMK Position: Q1 2023 in Review

Jane Street sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2023, closing a stake of 1,383 shares — an estimated $16.4K sold.

Jane Street first reported a position in DMK in Q1 2014 and held it in 12 quarters. The position peaked at $103K in Q1 2014. 47 funds tracked by Wall St. Rank hold DMK as of Q1 2023.

  • Jane Street reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 1,383 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2023, an estimated $16.4K.
  • Jane Street first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 12 quarters.
  • Jane Street's DMK Pharmaceuticals Corporation Common Stock position peaked at $103K in Q1 2014.
  • 47 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.